Dhindsa S, Ghanim H, Batra M, Kuhadiya N, Abuaysheh S, Green K
Clin Endocrinol (Oxf). 2016; 85(5):772-780.
PMID: 27292585
PMC: 5065401.
DOI: 10.1111/cen.13130.
Maggio M, De Vita F, Fisichella A, Lauretani F, Ticinesi A, Ceresini G
Int J Endocrinol. 2016; 2015:292574.
PMID: 26779261
PMC: 4686706.
DOI: 10.1155/2015/292574.
Bar C, Huber N, Beier F, Blasco M
Haematologica. 2015; 100(10):1267-74.
PMID: 26206796
PMC: 4591758.
DOI: 10.3324/haematol.2015.129239.
Beggs L, Yarrow J, Conover C, Meuleman J, Beck D, Morrow M
Am J Physiol Endocrinol Metab. 2014; 307(5):E456-61.
PMID: 25074984
PMC: 4154071.
DOI: 10.1152/ajpendo.00184.2014.
Pottinger T, Pickering A
Fish Physiol Biochem. 2013; 3(3):121-6.
PMID: 24233439
DOI: 10.1007/BF02180413.
Effect of testosterone undecanoate on hematological profiles, blood lipid and viscosity and plasma testosterone level in castrated rabbits.
Zhao C, Moon D, Park J
Can Urol Assoc J. 2013; 7(3-4):E221-5.
PMID: 23671530
PMC: 3650759.
DOI: 10.5489/cuaj.507.
Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature.
Stergiopoulos K, Brennan J, Mathews R, Setaro J, Kort S
Vasc Health Risk Manag. 2009; 4(6):1475-80.
PMID: 19337562
PMC: 2663437.
DOI: 10.2147/vhrm.s4261.
Low testosterone levels and the risk of anemia in older men and women.
Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A
Arch Intern Med. 2006; 166(13):1380-8.
PMID: 16832003
PMC: 2645631.
DOI: 10.1001/archinte.166.13.1380.
Androgen therapy for anemia in elderly uremic patients.
Navarro J, Mora C
Int Urol Nephrol. 2002; 32(4):549-57.
PMID: 11989543
DOI: 10.1023/a:1014491110361.
[Hematopoietic stimulation for enhanced bone marrow regeneration after chemotherapy (author's transl)].
Labedzki L, Noack D
Klin Wochenschr. 1980; 58(5):211-8.
PMID: 6772872
DOI: 10.1007/BF01476966.
Testosterone therapy for anaemia in maintenance dialysis.
Shaldon S, Koch K, OPPERMANN F, Patyna W, SCHOEPPE W
Br Med J. 1971; 3(5768):212-5.
PMID: 5559043
PMC: 1798542.
DOI: 10.1136/bmj.3.5768.212.
Suppression of erythropoiesis by administration of deoxycorticosterone and corticosterone.
Hogan G
Experientia. 1971; 27(3):331-2.
PMID: 5546665
DOI: 10.1007/BF02138179.
Regulation of erythropoiesis by androgens.
GARDNER F, Gorshein D
Trans Am Clin Climatol Assoc. 1973; 84:60-70.
PMID: 4199622
PMC: 2441277.
Effective erythropoiesis induced by 5beta-pregnane-3beta-hydroxy-20-one in squirrel monkeys.
Besa E, Gorshein D, Hait W, GARDNER F
J Clin Invest. 1973; 52(9):2278-82.
PMID: 4199416
PMC: 333031.
DOI: 10.1172/JCI107415.
Sex-related differences in hematological values. A study on the erythrocyte and granulocyte count, plasma iron and iron-binding proteins in human transsexuals on contrasexual hormone therapy.
Rosenmund A, Kochli H, KONIG M
Blut. 1988; 56(1):13-7.
PMID: 3337916
DOI: 10.1007/BF00321054.
Split dose studies on the erythropoietic effects of cadmium.
Hogan G, Razniak S
Bull Environ Contam Toxicol. 1992; 48(6):857-64.
PMID: 1568062
DOI: 10.1007/BF00201146.
Plasma erythropoietin assay in patients with chronic renal failure.
Davies S, Bisson M, Bisson P
J Clin Pathol. 1975; 28(11):875-8.
PMID: 1236627
PMC: 475887.
DOI: 10.1136/jcp.28.11.875.
[Erythropoietin in serum and urine in man upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl)].
Schulz E
Blut. 1977; 35(2):125-33.
PMID: 901950
DOI: 10.1007/BF00996292.
The onset of a refractory response to androgens in the anemia of bone marrow failure.
GARDNER F, Besa E
Trans Am Clin Climatol Assoc. 1977; 88:108-18.
PMID: 898530
PMC: 2441405.
